International Stem Cell (ISCO) Non-Current Assets (2010 - 2026)
International Stem Cell (ISCO) posted Non-Current Assets of $1.14 million for Q2 2026, down 33.5% from $1.71 million a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, International Stem Cell's Non-Current Assets came in at $1.41 million, down 12.7% from FY2024.
- Annual Non-Current Assets has declined for seven consecutive years, with a five-year compound annual growth rate of -14.6% (FY2020 to FY2025).
- In prior years, International Stem Cell's Non-Current Assets was $1.61 million in FY2024 (-13.7%), $1.87 million in FY2023 (-14.0%), $2.17 million in FY2022 (-16.8%) and $2.61 million in FY2021 (-15.9%).
- The Q2 2026 figure stands as the lowest quarterly Non-Current Assets in data going back to Q4 2010.
- On a year-over-year basis, Non-Current Assets increased in 1 of the last seven quarters, with an average decline of 12.3%.
- The strongest year-over-year quarter for Non-Current Assets in the past five years was Q1 2025, with growth of 0.6%; the weakest was Q2 2026, with a decline of 33.5%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 159.77 Bn |
| 10 | International Stem Cell | 2.08 Mn | -1.89 Mn | 1.46 Mn | 1.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Mn |
| Dec 31, 2025 | 1.41 Mn |
| Sep 30, 2025 | 1.55 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | 1.61 Mn |
| Sep 30, 2024 | 1.69 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Mar 31, 2024 | 1.78 Mn |
| Dec 31, 2023 | 1.87 Mn |
| Sep 30, 2023 | 1.98 Mn |
| Jun 30, 2023 | 2.10 Mn |
| Mar 31, 2023 | 2.11 Mn |
| Dec 31, 2022 | 2.17 Mn |
| Sep 30, 2022 | 2.34 Mn |
| Jun 30, 2022 | 2.42 Mn |
| Mar 31, 2022 | 2.54 Mn |
| Dec 31, 2021 | 2.61 Mn |
| Sep 30, 2021 | 2.45 Mn |
| Jun 30, 2021 | 2.83 Mn |
API Access
International Stem Cell Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();